Non-Invasive Measurement of Cardiac Output and Stroke Volume in PAH/CTEPH

NAEnrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 2, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

December 31, 2025

Conditions
Pulmonary Arterial HypertensionChronic Thromboembolic Pulmonary Hypertension
Interventions
DEVICE

Non-invasive hemodynamic measurements

A patient profile will be set up in the Edwards EV1000 clinical platform by inputting the patient's demographic information. One or two Edwards ClearSight finger cuffs will be placed on the index, middle, and/or ring finger on one hand of the patient. A pressure controller will be secured by a forearm strap where the finger cuffs will be connected to the pressure controller. The pressure controller will be connected to the Edwards EV1000 clinical platform monitor. A heart reference sensor (HRS) will be connected to the pressure controller, a finger cuff, and to the patient at heart level. The Edwards EV1000 clinical platform will calibrate the finger probes, then record measurements for 10-30 seconds. If two finger probes are available, measurements will alternate between fingers.

Trial Locations (1)

90095

Ronald Reagan UCLA Medical Center, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER